OrbiMed
Venture Capital
Global Healthcare & Biopharma
Early Stage
Pre-Seed
Seed
Late Stage
Growth
Biotech
Healthcare
- Headquarters
- New York, United States
- Founded
- 1989
- Website
- orbimed.com
- AUM
- $18.3B
- Portfolio Companies
- 211
- Last Investment
- Jan 2026
- Geographic Focus
- United States
Investment Thesis
Invests globally across the healthcare industry from seed-stage VC to large publicly-traded companies via public equity, private equity, and private credit/royalty strategies.
Portfolio211
P
PerfuE
EthrisZ
ZyloxH
HIRO
N
NorchemU
UquifaP
PerfuseAT
AER TherapeuticsII
Insmed IncorporatedFB
Forte BiosciencesCT
Convergent TherapeuticsN
Nucleix
D
DLabST
STAR TherapeuticsTP
Traws PharmaNH
Noctrix HealthIH
Innvolution HealthcareEH
Entero HealthcarePM
Proverum MedicalKT
Kartos TherapeuticsDX
Dami XiaomiUB
Upstream Bio
M
MDxHealthBO
Bonovo OrthopedicsB
Baili
CB
Cellipont BioservicesYC
Yangpu Chenxing MedicineS
StairmedKT
Keros TherapeuticsA
AnchordxSD
Suraksha DiagnosticTP
Terns Pharmaceuticals
RT
ReCode TherapeuticsBT
BlossomHill TherapeuticsMB
Mondego Bio